• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Stenosis (2263)
Event Date 06/13/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The 5.0 x 60 mm supera is being filed under a separate medwatch mfr number.
 
Event Description
It was reported the procedure was to treat an in-stent restenosis of a supera in the mid-distal superficial femoral artery (sfa).Balloon angioplasty was performed on the restenosis, at which time a dissection occurred under the supera stent.The decision was made to place another supera stent in the distal part of the sfa, overlapping the previously implanted supera stent.The 5 x 60 supera was advanced, but met resistance and the stent was pushed forward out of the catheter due to the pushing, the stent released before the release button was used.The stent was 1 1/2 cm still in the shaft and folded back for 1 cm.An extra balloon was used to dilate the section that was folded back of the stent.The patient is now under close monitoring in case of issues occurring in that area.Although it was reported there was a delay due to the additional percutaneous transluminal angioplasty (pta), the delay was not clinically significant as there was no adverse patient effects.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The incident information was reviewed; however, there was no reported device malfunction and the product was not returned as the stent remains in the anatomy.The reported patient effects of intimal dissection and restenosis are listed in the supera instructions for use, as known patient effects.The lot history record (lhr) for this product could not be reviewed and a similar incident query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.Based on the information reviewed, there is no indication of a product quality issue.Based on the case information a conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key5790968
MDR Text Key49436441
Report Number2024168-2016-04530
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/24/2016
Initial Date FDA Received07/13/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-